Athenex Announces Receipt of Positive Nasdaq Listing Determination
November 03, 2022 07:05 ET
|
Athenex, Inc.
BUFFALO, N.Y., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies...
Athenex Provides Third Quarter 2022 Financial Results and Business Update
November 03, 2022 07:00 ET
|
Athenex, Inc.
Bolstered balance sheet with $30 million public offering of common stock and warrantsNasdaq Hearing Panel grants Athenex’s request for continued listingAthenex is in the final stages of closing the...
Athenex 將於 2022 年 11 月 3 日公佈 2022 年第三季度企業和財務最新動態
October 24, 2022 12:21 ET
|
Athenex, Inc.
紐約州布法羅, Oct. 25, 2022 (GLOBE NEWSWIRE) -- 全球生物製藥公司 Athenex（納斯達克：ATNX）今天宣布，公司將於 2022 年 11 月 3 日星期四開市前公佈 2022 年第三季度企業和財務最新動態。該公司致力於探索和開發治療癌症及相關疾病的新型療法，並使其商業化。Athenex 的管理團隊將於美國東部時間上午 8:00...
Athenex to Provide Corporate and Financial Update for the Third Quarter 2022 on November 3, 2022
October 24, 2022 08:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the...
Athenex提交股東特別大會的受委代表聲明終定本
October 11, 2022 15:26 ET
|
Athenex, Inc.
股東特別大會將以虛擬會議形式於2022年11月22日上午9:30（東部時間）舉行 紐約水牛城, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ: ATNX)...
Athenex Files Definitive Proxy Statement for Special Stockholder Meeting
October 11, 2022 09:15 ET
|
Athenex, Inc.
Special Stockholder Meeting will be held as a virtual meeting on November 22, 2022 at 9:30 a.m. Eastern Time BUFFALO, N.Y., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc., (NASDAQ: ATNX), a global...
Athenex 將參加 H.C. Wainwright 第 24 屆年度全球投資會議
September 07, 2022 01:14 ET
|
Athenex, Inc.
紐約水牛城, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX) 是一家致力於發現、開發及將治療癌症與相關疾病的新療法商業化的全球生物製藥公司，今天宣佈管理層將出席 2022 年 9 月 12 日至 14 日在紐約州紐約市以虛擬方式舉行的 H.C. Wainwright 第 24 屆年度全球投資會議。...
Athenex to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
September 06, 2022 11:00 ET
|
Athenex, Inc.
BUFFALO, N.Y., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for...
Athenex, Inc. 宣佈 3,000 萬美元公開發行普通股和認股權證
August 11, 2022 22:11 ET
|
Athenex, Inc.
約水牛城, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (「Athenex」) (Nasdaq: ATNX) 是一家致力於研究、開發及將治療癌症新療法商業化的全球生物製藥公司，今天宣佈其 35,333,334 股普通股和隨附認股權證的承銷公開發售定價，以每股 0.75 美元的合併公開發售價格和隨附認股權證購買最多 35,333,334...
Athenex, Inc. 宣佈擬議承銷公開發行普通股和認股權證
August 11, 2022 07:33 ET
|
Athenex, Inc.
紐約水牛城, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (「Athenex」) (Nasdaq: ATNX)...